Clinical Trial Update: Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn [NA]

View source ↗

Summary

Clinical trial update on using cystatin C–based estimation of glomerular filtration rate to prevent contrast-induced nephropathy with N-acetylcysteine or zinc i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Contrast-induced Nephropathy

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• ZINC (Zinc chloride)

Snippet

Sponsor: Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | Conditions: Chronic Kidney Failure | NA | Status: TERMINATED